Constellation Energy (CEG) narrows 2025 outlook after Q3 EPS miss; CEG stock slips today (07.11.2025)

Constellation Energy (CEG) narrows 2025 outlook after Q3 EPS miss; CEG stock slips today (07.11.2025)

Constellation Energy Corporation (NASDAQ: CEG) reported third‑quarter results this morning, tightening its full‑year 2025 earnings guidance after a modest earnings miss. Adjusted operating EPS came in at $3.04, below the LSEG consensus (~$3.12), on $6.57 billion in revenue, up slightly year over year. The company now sees 2025 adjusted EPS of $9.05–$9.45 (midpoint $9.25). Shares traded lower in early action on the update. [1]

Key takeaways (as of 07.11.2025)

  • EPS miss, revenue essentially flat: Q3 adjusted operating EPS $3.04 vs. consensus near $3.12; revenue $6.57B vs. $6.55B a year ago. GAAP EPS $2.97. Guidance narrowed to $9.05–$9.45 for FY25. [2]
  • Stock reaction: CEG shares traded lower intraday following the print (see live chart above). External coverage also noted a break below recent technical levels. [3]
  • Operations strong: Nuclear fleet output rose to 46,477 GWh with a 96.8% capacity factor (ex‑Salem/STP). Management cited “favorable market and portfolio conditions,” partly offset by lower nuclear PTC revenue tied to higher anticipated gross receipts. [4]
  • Hydro milestone: Maryland issued a revised water quality certification for the Conowingo Dam, clearing the path to re‑licensing after a $340 million settlement announced last month. [5]

What moved the numbers

Earnings vs. expectations. Constellation posted adjusted operating EPS of $3.04; analysts were looking for roughly $3.12. Total operating expenses increased about 7.8% year over year to $5.48B, pressuring margins, while revenue ticked up to $6.57B from $6.55B. [6]

Guidance tightened. Full‑year 2025 adjusted EPS was narrowed to $9.05–$9.45 (from $8.90–$9.60 previously). Several outlets noted the midpoint sits below some street estimates (e.g., FactSet near $9.49). [7]

Fleet performance. Nuclear operations remained a bright spot: output climbed to 46,477 GWh and the capacity factor improved to 96.8% (ex‑Salem/STP). Planned refueling days fell to 23 (from 37 a year ago), and non‑refueling outage days dropped to 5 (from 20). [8]


Strategy & policy context investors are watching

Conowingo Dam re‑licensing back on track. In October 2025, Maryland’s Department of the Environment issued a revised Water Quality Certification for Conowingo—part of a $340 million settlement addressing sediment, debris, fish passage and other Chesapeake Bay impacts. Constellation highlighted the certification in today’s release as a key step to long‑term operation of the hydro facility. [9]

Maryland build‑out plan (Nov. 4). Earlier this week, Constellation proposed up to 5,800 MW of new generation and battery storage in Maryland to meet rising demand—~800 MW battery storage, >700 MW fast‑track gas units convertible to hydrogen, uprates and potential 2,000 MW of next‑gen nuclear at Calvert Cliffs, plus a 1,000 MW “virtual power plant” via expanded demand response. [10]

Calpine acquisition still approaching the finish line. The company reiterated it is “approaching the close” of the Calpine transaction. Key approvals—including FERC—have been secured; the deal has been expected to close in Q4 2025, pending remaining conditions. [11]


Market reaction and coverage

Financial press framed the day as a mixed report: healthy operations and secular demand tailwinds for data‑center power offset by the EPS shortfall and tighter guidance. Some technical analysts noted the stock slipping below a recent buy point on the news. [12]


By the numbers (Q3 2025)

  • GAAP EPS:$2.97; Adjusted operating EPS:$3.04 (vs. $2.74 in Q3’24)
  • Revenue:$6.57B (vs. $6.55B in Q3’24)
  • Nuclear output:46,477 GWh; Capacity factor:96.8% (ex‑Salem/STP)
  • Guidance (FY25):$9.05–$9.45 adjusted EPS
  • Earnings call:Today at 10:00 a.m. ET (webcast on the investor site)
    [13]

What’s next

  • Management webcast at 10:00 a.m. ET with slides posted to the investor site; look for color on price hedges, outage cadence, and Calpine integration milestones. [14]
  • Regulatory milestones to watch: final FERC licensing steps for Conowingo and remaining closing conditions for Calpine. [15]

Context & recent corporate actions

  • Dividend: The board declared a quarterly dividend of $0.3878 per share (record Nov. 17, payable Dec. 5, 2025). [16]

Sources

Company press release and filings; independent news coverage and state agency documents. Key references: Constellation Q3 2025 results release; Reuters earnings coverage; FT/Business Wire postings of the release; MDE documentation on Conowingo; and additional market coverage. [17]


This article is for informational purposes only and is not investment advice.

Constellation Energy CEO: We're seeing load growth despite stock performance

References

1. www.reuters.com, 2. www.reuters.com, 3. www.investors.com, 4. www.constellationenergy.com, 5. www.constellationenergy.com, 6. www.reuters.com, 7. www.reuters.com, 8. www.constellationenergy.com, 9. mde.maryland.gov, 10. www.constellationenergy.com, 11. www.constellationenergy.com, 12. www.investors.com, 13. www.constellationenergy.com, 14. www.constellationenergy.com, 15. mde.maryland.gov, 16. www.businesswire.com, 17. www.constellationenergy.com

Stock Market Today

  • CNH Industrial Q3 Earnings Miss; Zacks Rank #4 Sell Signals Near-Term Underperformance
    November 7, 2025, 11:02 AM EST. CNH Industrial (CNH) reported Q3 EPS of $0.08, missing the Zacks Consensus of $0.13 and down from $0.24 a year ago. After adjustments, the miss is -38.46%. The company posted revenue of $4.4B, beating the consensus by 2.21%. In the last four quarters, CNH beat estimates twice. The stock carries a Zacks Rank #4 (Sell), reflecting unfavorable near-term earnings revisions. Management commentary on the earnings call will dictate sentiment. Looking ahead, the current consensus calls for $0.16 per share on $4.78B in next quarter revenue and $0.57 on $17.62B for the current fiscal year. Year-to-date, CNH has declined about 9.4% versus the S&P 500's gain.
  • Hologic's Breast Health Rebounds as Buyout Talks Intensify
    November 7, 2025, 11:00 AM EST. Hologic's Breast Health segment rebound anchors the stock narrative after Q4 FY2025, with revenues up 4.8% to $393.7 million driven by interventional products, the Endomagnetics addition, and improved U.S. sales execution. On an organic basis, growth still held at 3.3% excluding the divested SSI and Endomagnetics July impact. The year featured leadership changes to sharpen the go-to-market, rebalancing the sales force between capital and disposable lines and rolling out an end-of-life plan for older gantries. A North America direct-sales push for Endomagnetics broadened distribution. In late October, Hologic disclosed a proposed buyout by private equity firms Blackstone and TPG, valuing the deal at up to $79 per share with a CVR of up to $3, payable on 2026-2027 revenue milestones, shifting strategic emphasis onto the division.
  • BMO Capital Markets raises Lyft price target to $23 with market perform rating
    November 7, 2025, 10:58 AM EST. BMO Capital Markets boosted Lyft's price target from $20.00 to $23.00 and kept a market perform rating, signaling about a 14.54% upside from the prior close. The update comes alongside other analyst movements, including Bank of America lifting its target from $12 to $14 with an underperform rating, Benchmark reiterating a Buy, and Deutsche Bank Aktiengesellschaft raising its target to $21 with a Hold rating. Market participants show a mixed tape: Wall Street Zen trimmed rating, Wedbush lifting to $20 with Neutral; overall Street consensus from MarketBeat sits at Hold with an average price target around $19.88. LYFT traded around $20.08 as investors digested the earnings report, where the company posted $0.13 per share vs $0.30 expected, with $1.69B revenue.
  • Graham (GHM) Q2 Earnings Miss vs. Estimate; Revenue Beats
    November 7, 2025, 10:56 AM EST. Graham (GHM) reported Q2 earnings of $0.31 per share, short of the Zacks consensus of $0.33 and down from a year-ago $0.31. The quarterly result includes non-recurring adjustments and represents a -6.06% surprise. Revenue came in at $66.03 million, beating the street by 12.67% versus the prior year's $53.56 million. Management commentary on the call will drive the stock's near-term moves, with a YTD gain of around 39.7% vs. the S&P 500's 14.3%. Ahead, the current-quarter consensus is $0.27 on $52.61 million in revenue, and the full year is $1.42 on $230.61 million in revenue. The stock carries a Zacks Rank #3 (Hold), implying performance in line with the market in the near term.
  • Essent Group Q3 EPS Misses Estimates; Revenue Beat; Outlook Mixed
    November 7, 2025, 10:52 AM EST. Essent Group (ESNT) posted Q3 earnings of $1.67 per share, missing the Zacks Consensus of $1.75 - a -4.57% surprise. Excluding non-recurring items, the result compares with $1.65 a year earlier. The quarter's revenue was $311.83 million, topping the consensus by 1.18% and edging down from the prior year's $316.58 million. Over the last four quarters, Essent has beat EPS estimates twice and revenue estimates three times. The stock has risen about 11.7% YTD, versus the S&P 500 gain of about 14.3%. Looking ahead, the current-quarter EPS is seen at $1.79 on $310.92 million in revenue, with the full year at $7.11 on $1.26 billion. Management commentary on the call will be key; the current Zacks Rank remains #3 Hold.
Opendoor (OPEN) plunges after Q3 miss as new CEO pivots to “AI company,” unveils tradable-warrant dividend — Nov 7, 2025
Previous Story

Opendoor (OPEN) plunges after Q3 miss as new CEO pivots to “AI company,” unveils tradable-warrant dividend — Nov 7, 2025

Thanksgiving Travel: Allegiant Air Sounds Alarm as FAA Cuts Flights 10% Amid Ongoing Shutdown (Nov. 7, 2025)
Next Story

Thanksgiving Travel: Allegiant Air Sounds Alarm as FAA Cuts Flights 10% Amid Ongoing Shutdown (Nov. 7, 2025)

Go toTop